{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:40:32Z","timestamp":1779183632124,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1117510"],"award-info":[{"award-number":["APP1117510"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1113531"],"award-info":[{"award-number":["APP1113531"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1122952"],"award-info":[{"award-number":["APP1122952"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014555","name":"Murdoch Children's Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.nmd.2021.07.007","type":"journal-article","created":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T06:35:39Z","timestamp":1627108539000},"page":"1081-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic neuromuscular disorders: what is the best that we can do?"],"prefix":"10.1016","volume":"31","author":[{"given":"Nigel G","family":"Laing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royston W.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianina","family":"Ravenscroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2021.07.007_bib0001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2021.07.007_bib0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acn3.51002","article-title":"Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience","volume":"7","author":"Beecroft","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0003","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1001\/jamaneurol.2015.2274","article-title":"Use of Whole-exome sequencing for diagnosis of limb-girdle muscular dystrophy: outcomes and lessons learned","volume":"72","author":"Ghaoui","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WCO.0000000000000374","article-title":"Next-generation sequencing in neuromuscular diseases","volume":"29","author":"Efthymiou","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nmd.2021.07.007_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014006","article-title":"Clinical care recommendations for cardiologists treating adults with myotonic dystrophy","volume":"9","author":"McNally","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nmd.2021.07.007_bib0007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10408363.2012.658906","article-title":"Genetics of neuromuscular disorders","volume":"49","author":"Laing","year":"2012","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.nmd.2021.07.007_bib0008","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","article-title":"Carrier screening for recessive disorders","volume":"20","author":"Antonarakis","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0009","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp.26.4.322","article-title":"Myopathic changes in a muscular dystrophy carrier","volume":"26","author":"Dubowitz","year":"1963","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2021.07.007_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1469-8749.1975.tb04674.x","article-title":"Carrier detection and genetic counseling in duchenne dystrophy","volume":"17","author":"Dubowitz","year":"1975","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0011","first-page":"232","article-title":"The muscular dystrophies: results of carrier detection and genetic counseling in Western Australia. records of the adelaide children's","volume":"1","author":"Kakulas","year":"1977","journal-title":"Hospital"},{"key":"10.1016\/j.nmd.2021.07.007_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5694\/j.1326-5377.1991.tb112839.x","article-title":"The diagnosis of Duchenne and Becker muscular dystrophies: two years' experience in a comprehensive carrier screening and prenatal diagnostic laboratory","volume":"154","author":"Laing","year":"1991","journal-title":"Med J Aust"},{"key":"10.1016\/j.nmd.2021.07.007_bib0013","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/cge.13206","article-title":"Patient actions and reactions after receiving negative results from expanded carrier screening","volume":"93","author":"Kraft","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0014","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/brain\/awt315","article-title":"Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2","volume":"137","author":"Foley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2021.07.007_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/nyas.13538","article-title":"Therapeutic strategies for congenital myasthenic syndromes","volume":"1412","author":"Lee","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2021.07.007_bib0016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12910-021-00623-5","article-title":"Priority setting at the clinical level: the case of nusinersen and the Norwegian national expert group","volume":"22","author":"Magelssen","year":"2021","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.nmd.2021.07.007_bib0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2017.02.006","article-title":"Diagnosis of Duchenne muscular dystrophy in Italy in the last decade: critical issues and areas for improvements","volume":"27","author":"D'Amico","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2021.07.007_bib0018","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/gim.2017.134","article-title":"Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests","volume":"20","author":"Archibald","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2021.07.007_bib0019","first-page":"37","article-title":"Molecular genetics and genetic counseling for Duchenne\/Becker muscular dystrophy","volume":"3","author":"Laing","year":"1993","journal-title":"Mol Cell Biol Hum Dis Ser"},{"key":"10.1016\/j.nmd.2021.07.007_bib0020","series-title":"Proceedings of the first congress of the world muscle society","article-title":"Spinal muscular atrophy following sperm donated pregnancy","author":"Winship","year":"1996"},{"issue":"126A","key":"10.1016\/j.nmd.2021.07.007_bib0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.a.20409","article-title":"Contribution of malformations and genetic disorders to mortality in a children's hospital","author":"Stevenson","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2021.07.007_bib0022","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/gim.2016.143","article-title":"The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort","volume":"19","author":"Walker","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2021.07.007_bib0023","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mus.24965","article-title":"Health care utilization and costs for children and adults with duchenne muscular dystrophy","volume":"53","author":"Teoh","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.07.007_bib0024","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1038\/s41598-021-82725-z","article-title":"Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy","volume":"11","author":"Beckers","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2021.07.007_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41436-019-0673-0","article-title":"The implementation of newborn screening for spinal muscular atrophy: the Australian experience","volume":"22","author":"Kariyawasam","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2021.07.007_bib0026","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","article-title":"Responsible implementation of expanded carrier screening","volume":"24","author":"Henneman","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.1988.00520250090026","article-title":"Mutants in Duchenne muscular dystrophy. Implications for prevention","volume":"45","author":"Roses","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0028","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/pd.5611","article-title":"International perspectives on the implementation of reproductive carrier screening","volume":"40","author":"Delatycki","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.nmd.2021.07.007_bib0029","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/AOG.0000000000001951","article-title":"\u202fCommittee opinion no. 690: carrier screening in the age of genomic medicine","volume":"129","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.31128\/AJGP-10-18-4725","article-title":"Preconception and antenatal carrier screening for genetic conditions: the critical role of general practitioners","volume":"48","author":"Delatycki","year":"2019","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.nmd.2021.07.007_bib0031","series-title":"Increasing options, informing choice: a report on preconception genetic testing and screening","first-page":"1","year":"2011"},{"key":"10.1016\/j.nmd.2021.07.007_bib0032","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bioe.12555","article-title":"The aims of expanded universal carrier screening: autonomy, prevention, and responsible parenthood","volume":"33","author":"van der Hout","year":"2019","journal-title":"Bioethics"},{"key":"10.1016\/j.nmd.2021.07.007_bib0033","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/ajo.13206","article-title":"Socioeconomic status and uptake of reproductive carrier screening in Australia","volume":"60","author":"Robson","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.nmd.2021.07.007_bib0034","doi-asserted-by":"crossref","first-page":"65ra4","DOI":"10.1126\/scitranslmed.3001756","article-title":"Carrier testing for severe childhood recessive diseases by next-generation sequencing","volume":"3","author":"Bell","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nmd.2021.07.007_bib0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41431-020-0685-x","article-title":"Gene selection for the Australian reproductive genetic carrier screening project (\"Mackenzie's mission\")","volume":"29","author":"Kirk","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0036","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pd.5437","article-title":"Expanded carrier screening for autosomal recessive conditions in health care: arguments for a couple-based approach and examination of couples' views","volume":"39","author":"Plantinga","year":"2019","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.nmd.2021.07.007_bib0037","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ejhg.2016.43","article-title":"Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases","volume":"24","author":"Plantinga","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0038","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jmedgenet-2018-105362","article-title":"Measuring the impact of genetic knowledge on intentions and attitudes of the community towards expanded preconception carrier screening","volume":"55","author":"Ong","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2021.07.007_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028209","article-title":"Study protocol of a multicentre cohort pilot study implementing an expanded preconception carrier-screening program in metropolitan and regional Western Australia","volume":"9","author":"Ong","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.nmd.2021.07.007_bib0040","unstructured":"R. Casella. Mackenzie\u2019s Mission: How one family turned tragedy into hope and love. Allen & Unwin 2020."},{"key":"10.1016\/j.nmd.2021.07.007_bib0041","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/j.nmd.2017.06.540","article-title":"Neuromuscular disorders genetics: what is the best that we can do?","volume":"27","author":"Laing","year":"2017","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:14:03Z","timestamp":1778789643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621001899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0960896621001899"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic neuromuscular disorders: what is the best that we can do?","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}